Latest Headlines

1. INFORS HT Launches Multifors 3 BenchTtop Bioreactor For Process Development 9/24/2026

   Multifors 3 is what bench-scale parallel bioprocessing should look like in 2026. It's built around a simple idea: the bioreactor should capture and retain the information that matters, so scientists can focus on their process. PID settings, cascades, hardware configuration, and sensor metadata are documented automatically, helping teams reproduce the complete process configuration.

2. Andelyn Biosciences To Implement Curator® Platform To Develop And Manufacture Gene Therapy AAV9-GM2 For Queen's University To Treat GM2 Gangliosidoses 9/21/2026

   Andelyn Biosciences, Inc., a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy candidate for the treatment of GM2 gangliosidoses, such as Tay-Sachs and Sandhoff diseases.

3. Andelyn Biosciences And Its Curator® Platform Achieve First FDA-Approved Commercial Gene Therapy Manufacturing Milestone Following The FDA's Approval Of Ultragenyx's Fayuvi™ For The Treatment Of Sanfilippo Syndrome Type A (MPS IIIA) 9/21/2026

   Andelyn Biosciences (“Andelyn”), a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (“CDMO”), today announced that it is now manufacturing Fayuvi™ (rebisufligene etisparvovec-hopf), an FDA-approved gene therapy, for commercial supply at its Columbus, Ohio facility. 

4. Emulate Enters Final Stage Of FDA ISTAND Program For Human Liver-Chip With Submission Of Qualification Package Covering Both Zoë® And AVA™ Organ-Chip Platforms 9/18/2026
5. Samsung Biologics Signs USD 262 Million Manufacturing Agreement With European Pharmaceutical Company 9/15/2026

   Samsung Biologics’ new $262 million manufacturing agreement, extending through 2033, underscores strong long-term demand and business momentum as the company rapidly expands its global capacity, capabilities, and portfolio to support continued growth.

6. ABEC Opens New Manufacturing Facility In Wilson, North Carolina 9/14/2026

   ABEC, a global leader in customized solutions and services for biopharmaceutical manufacturing, announced the grand opening of its newest manufacturing facility in Wilson, North Carolina. The official ribbon-cutting ceremony and facility opening celebration will take place on September 24, 2026, at 9:00am, bringing together company leadership, employees, partners, and community leaders to mark this significant milestone in ABEC's continued growth.

7. Insights From GRAM At CPHI Milan 2026: Navigating The Future Of Sterile Manufacturing 9/9/2026

   As biologics manufacturing evolves, Contract Development and Manufacturing Organizations (CDMOs) are becoming increasingly pivotal. At CPHI Milan, October 6 – 8, 2026, Grand River Aseptic Manufacturing (GRAM) will showcase its innovative capabilities, particularly in aligning manufacturing capacity and capabilities with clients’ long-term goals, at booth #8A26.

8. Ardena To Attend CPHI Worldwide Milan 2026, Launching Charity Step Challenge "From Molecules To Miles" 9/9/2026

   Ardena, a full-service contract development and manufacturing organization (CDMO) supporting pharmaceutical companies from molecule to market, will participate in CPHI Worldwide, taking place October 6-8, 2026, in Milan, Italy.

9. Lifecore Biomedical Signs Agreement For Commercial Site Transfer Supporting Global Pharmaceutical Company 9/2/2026

   Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced it has signed a new agreement to transfer a commercially marketed product to the company’s pipeline.

10. Andelyn Biosciences To Scale Manufacturing For Genprex's Diabetes Gene Therapy Program 9/1/2026